COBALT represented MediCA Group in the largest healthcare clinic merger in Lithuania

COBALT successfully represented MediCA Group in the largest healthcare clinic merger in Lithuania. A merger of two leading private medicine networks InMedica and MediCA Group took 1.5 years to complete.

Post-transaction, one of the largest Baltic private equity funds INVL Baltic Sea Growth Fund (through its special purpose vehicle BSGF Sanus) remains the largest shareholder with an ownership stake of 45% of InMedica shares, 40% is owned by the largest Latvian private medicine group Repharm and the remaining 15% is held by Lithuanian company Litgaja. The business will be managed by a joint management team made of MediCA Group and InMedica professionals.

COBALT advised the client throughout all stages of the transaction. The team consisted of COBALT Partner Elijus Burgis, Partner Rasa Zaščiurinskaitė, Senior Associate Julija Aleška and Senior Associate Laura Ryzgelytė.